News | June 02, 2015

Cincinnati Children’s Hospital Sees Potential of Synthetic MRI for Pediatrics

Technology creates multiple diagnostic sequences from a single acquisition, which could shorten exam time

SyMRI, Cincinnati, CCHMC, synthetic MRI, pediatrics

Image courtesy of SyntheticMR AB

June 2, 2015 — Cincinnati Children’s Hospital Medical Center (CCHMC) has evaluated synthetic magnetic resonance imaging (MRI) on pediatric cases to study and clinically validate its use on children. Results from the first part of the evaluation, which used SyMRI software, shows the synthetic images are diagnostically satisfactory in comparison with conventional sequences.

Long examination times are particularly challenging when examining children, who may even need to be given a general anesthetic during the exam. A faster workflow would therefore be especially valuable for pediatric applications. CCHMC sees an opportunity to improve the efficiency of pediatric MRI by being able to shorten the examination time with SyMRI. Synthetic imaging is being evaluated on pediatric cases at CCHMC in two steps. At first it has been ensured that the synthetic images are diagnostically sufficient in comparison with conventional sequences.

SyntheticMR AB develops and markets new MRI software solutions. It created the SyMRI Image software that provides fast MRI workflows, allowing high patient throughput, and SyMRI Neuro that enables automatic segmentation of brain tissue, providing objective decision support based on quantitative data. SyMRI is a CE-marked product. A customized version of SyMRI Image was introduced at the 2014 Radiological Society of North America (RSNA) annual meeting by SyntheticMR’s strategic partner GE Healthcare under the name MAGiC for GE’s line of Signa MRI systems.

“Because of the way the brain develops, a true strength of synthetic imaging that could be particularly useful in pediatric cases is the possibility of tuning image contrast afterwards and generating contrasts that usually are not acquired. Therefore the use of synthetic imaging, including interactive contrast changes during review, is now ongoing as the second step of evaluation. The ability to create multiple diagnostic sequences from a single acquisition may allow for substantial time savings and increased throughput”, said Blaise V. Jones, M.D., chief of neuroradiology, Cincinnati Children’s Hospital Medical Center.

While clinical validation of synthetic MRI relative to standard pulse sequences has been performed in adults, no such data has previously been available on children. The study at CCHMC evaluates synthetic MRI in children by comparing synthetic MR images with conventional MR images in children at both 1.5 and 3.0T in a blinded fashion to determine image quality and diagnostic efficacy relative to standard MRI.

“We see great potential for its use in clinical practice, and anticipate that synthetic imaging is going to help us discern subtle differences at grey matter to white matter interfaces, for example in epilepsy cases. Furthermore we expect that the quantitative T1, T2 and PD maps can assist us in monitoring the myelination process of white matter during the first years of brain development”, Jones continued.

SyMRI IMAGE from SyntheticMR optimizes the MRI workflow and shortens scan time using synthetic MRI. This is achieved by a single MR quantification scan of 5-7 minutes. Based on this single scan, conventional standard T1W, T2W and FLAIR images and any other combination of TE, TR and TI can be shown without rescanning the patient, allowing a substantial reduction in examination time.

For more information: www.symri.com

Related Content

GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
European Medicines Agency Issues Update on Gadolinium Contrast Agents
News | Contrast Media| August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI)| August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Cardiac CT scan showing plaque and calcification in the coronary arteries, from a Toshiba CT scanner
News | Business| July 19, 2017
July 19, 2017 — The Society of Cardiovascular Computed Tomography (SCCT) created a reimbursement fee chart for cardia
German Workshop Highlights Possibilities of Perfusion MRI
News | Stroke| July 03, 2017
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Toshiba Medical Introduces Vantage Titan Zen Edition MR
Technology | Magnetic Resonance Imaging (MRI)| June 27, 2017
June 27, 2017 — Toshiba Medical, a Canon Group company, introduced its newest...
Overlay Init